SCHEMBL628048

SCHEMBL628048

O=S(=O)(O)OCCCc1cccs1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 3/20 0.51
TSHR P16473 2/20 0.51
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TAAR1 Q96RJ0 1/20 0.47
NPC1 O15118 3/20 0.47
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 1/20 0.40
MAPT P10636 1/20 0.39
CYP2C19 P33261 1/20 0.39
USP2 O75604 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29003425 0.90 TAAR1 (0.46) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL8914039 0.79 NPC1 (0.49) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL9209882 0.78 NPC1 (0.48) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL2886265 0.77 TAAR1 (0.52) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL25306776 0.76 TAAR1 (0.59) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL2886363 0.76 TAAR1 (0.50) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL7198596 0.76 TAAR1 (0.50) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL2886603 0.75 TAAR1 (0.48) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL2888284 0.75 TAAR1 (0.48) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1
SCHEMBL2886419 0.75 TAAR1 (0.48) SMN1; SMN2ALDH1A1TSHRPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1693370-B1 SULFOXYALKYLTHIOPHENE COMPOUND AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2012-02-22 EP disclosed
US-7442485-B2 Lithographic process involving on press development FUJIFILM CORPORATION (JP) 2008-10-28 US disclosed
US-7371873-B2 Sulfoxyalkylthiophene and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-05-13 US disclosed
US-20070260071-A1 Sulfoxyalkylthiophene and Process for Producing the Same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2007-11-08 US disclosed
EP-1693370-A1 SULFOXYALKYLTHIOPHENE COMPOUND AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2006-08-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070260071-A1 Sulfoxyalkylthiophene and Process for Producing the Same TST, SULT1A1, MPST SMN1; SMN2 2980/4885ALDH1A1 228/4885TSHR 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.